Cargando…
Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations
Prostate cancer (PCa) is the most frequently diagnosed malignancy and second leading cause of cancer mortality in American males. Notably, men of African descent in the United States and Caribbean have the highest PCa mortality rates compared to men with European ancestry. Although current therapeut...
Autores principales: | Reed, Dominique, Raina, Komal, Agarwal, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060229/ https://www.ncbi.nlm.nih.gov/pubmed/30062144 http://dx.doi.org/10.1038/s41698-018-0058-x |
Ejemplares similares
-
Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy
por: Mozarowski, Paul, et al.
Publicado: (2021) -
Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation
por: Gillham, Charles M, et al.
Publicado: (2007) -
Colorectal Cancer in the Elderly Patient: The Role of Neo-adjuvant Therapy
por: Dodaro, Concetta Anna, et al.
Publicado: (2019) -
Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells
por: Punia, Reenu, et al.
Publicado: (2017) -
Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo‐Adjuvant Hormonal Therapy in Prostate Cancer Patients
por: Asai, Akihiro, et al.
Publicado: (2016)